New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:51 EDTNLNKNewLink Genetics price target raised to $40 from $23 at RW Baird
Baird raised its price target on NewLink Genetics on expectations of a fairly strong and aggressive uptake of IDO-inhibitor indoximod for many types of cancer. Shares are Outperform rated.
News For NLNK From The Last 14 Days
Check below for free stories on NLNK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
10:00 EDTNLNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:27 EDTNLNKNewLink Genetics initiated with a Buy at Mizuho
Subscribe for More Information
September 4, 2014
09:06 EDTNLNKOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PVH Corp. (PVH), up 9%... Verifone (PAY), up 3.8%... Methode Electronics (MEI), up 13%... Bazaarvoice (BV), up 9%. ALSO HIGHER: Bolt Technology (BOLT), up 35.7% after Teledyne (TDY) agrees to acquire the company for $22 per share in cash... Mitek Systems (MITK), up 58% after USAA lawsuit settlement... Tibco Software (TIBX), up 7% after announcing that it is reviewing strategic alternatives... Stereotaxis (STXS), up 22% after receiving FDA clearance for Vdrive with V-Loop system... NewLink (NLNK), up 3.4% after reporting FDA approval for Phase 1 clinical studies of Ebola vaccine. DOWN AFTER EARNINGS: Ciena (CIEN), down 3%... Joy Global (JOY), down 1%... Matrix Service (MTRX), down 11%... Mobileye (MBLY), down 1.3%. ALSO LOWER: Yum! Brands (YUM), down 2.8% after updating third quarter China division same-store sales guidance... 3D Systems (DDD), down 2.9% after downgraded at Pacific Crest... GoPro (GPRO), down 3.5% after downgraded at JPMorgan... Shanda Games (GAME), down 4% after announcing reconstitution of special committee.
07:23 EDTNLNKNewLink reports FDA approval for Phase 1 clinical studies of Ebola vaccine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use